COMMUNIQUÉS West-GlobeNewswire

Merit Medical Announces Global Operations Leadership Transition
19/08/2026
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as [...]
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19/08/2026
HIGH POINT, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
19/08/2026
Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector MIAMI, Aug. 19, 2026 (GLOBE NEWSWIRE [...]
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2026
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
Edesa Biotech Announces Proposed Public Offering
19/08/2026
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno- [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2026
WOBURN, Mass., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of [...]
FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device
19/08/2026
Authorization supports innovative approach to blood collection; may help address growing phlebotomist shortage Silver Spring, Md., Aug. 19, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today authorized [...]
Southern Sky Brands Announces Three New Vape Products in Collaboration with Martin’s in Jackson, Mississippi, Portions of Proceeds to Benefit Veterans Charity
19/08/2026
CANTON, Miss., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Southern Sky Brands is proud to announce the launch of three new vape products created in collaboration with Martin’s, the legendary Mississippi destination known for [...]
What Clinicians Evaluate Before Prescribing Low Dose Naltrexone Online
19/08/2026
Provn connects adults 18 and older with independent, U.S.-licensed clinicians who determine whether compounded low-dose naltrexone is medically appropriate. If prescribed, the strength, titration schedule, and [...]
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
19/08/2026
FOP is an ultra-rare genetic disorder characterized by rogue bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability Approval based on results from [...]
Interim Report Q2 2026: Successful reception of Evolve3 headsets and gross margin improvement boding well for strong H2 2026
19/08/2026
Highlights The Enterprise division delivered organic revenue growth of -7%, while the organic revenue growth excl. FalCom ended at -3%. The development reflects continued strong growth in North America and APAC. The [...]
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
19/08/2026
COPENHAGEN, Denmark – August 19, 2026. Novonesis delivered strong first half of 2026 at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% (previously 5-7%), and the adjusted EBITDA margin [...]
Interim report H1 2026
19/08/2026
Strong first half year at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% and the adjusted EBITDA margin expected at the higher end of the 37-38% range. Inaugural share buy-back program [...]
Announcement of share buyback program
19/08/2026
The Board of Directors of Novonesis has approved an inaugural multi-year share buyback program in a total amount of EUR 1 billion to be initiated during the second half of 2026 and expected to be completed by the end of [...]
Increased outlook for 2026
19/08/2026
Novonesis increases its full year 2026 organic sales growth outlook from 5-7% to now 7-8% based on a stronger performance so far in the year and the expectations for the rest of the year. Following the stronger sales [...]
BC health research pursues precision, genetics-based care for three conditions
19/08/2026
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) -- A person’s DNA can help predict suitable treatments, medications and nutrition for them, leading to better personalized care. Three Genome British Columbia [...]
DAZED INC. POWERING FORWARD: ANNOUNCES DALLAS EXPANSION BRINGING STORE COUNT TO 13, STRONGER Q2 2026 FINANCIALS, Q4 STOCK BUYBACK PLAN, AND DISTRIBUTION ACCELERATION
19/08/2026
Lazydaze Coffeeshop Expands to Dallas, Releases Q2 Reports and Capitalizes on Distribution Austin, Texas , Aug. 19, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE August 18, 2026 — Dazed Inc. (OTC: DAZD), formerly MedX [...]
SafeSpace Global and BMRT Security Enter Binding Exclusive Agreement to Advance Detection of Concealed Weapons and Drugs for America’s Schools and Correctional Facilities
19/08/2026
Using AI to spot the guns and drugs BEFORE they KILL. KNOXVILLE, Tenn., Aug. 19, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (“SafeSpace Global” or the “Company”), a publicly traded, multimodal [...]
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
19/08/2026
Highest Q2 and H1 revenue in Company history , reflecting strength across all core segments and reaching a new milestone with an adjusted annualized revenue run-rate exceeding $75 million Continued progress toward [...]

Pages